siRNA treatment lowers triglycerides in people along with rare disorder

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran minimized triglyceride levels by 80% as well as decreased the threat of pancreatitis in clients with constant chylomicronemia, with or even without a hereditary prognosis.